Summary

Middle East and Africa inflation device market is expected to reach USD 41.82 million by 2032, from USD 33.79 million in 2024, growing at the CAGR of 2.7% in the forecast period of 2025 to 2032.
Market Segmentation:
Middle East and Africa Inflation Device Market, By Type (Analog Inflation Device and Digital Inflation Device), Capacity (20ml Inflation Device, 25ml Inflation Device, 30ml Inflation Device, and 60ml Inflation Device), Application (Interventional Cardiology, Peripheral Vascular Procedures, Interventional Radiology, Urological Procedures, Gastroenterological Procedures, and Others), Pressure (30 atm, 40 atm, 55 atm, and Others), Function (Stent Deployment and Fluid Delivery), End User (Hospitals, Interventional Laboratories, and Clinics), Distribution Channel (Direct Tender, Retail Sales, and Third Party Distributors), Country (Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa) – Industry Trends and Forecast to 2032
Overview of Middle East and Africa Inflation Device Market Dynamics:
Driver
• Rising case of cardiovascular diseases
Restraint
• High cost of advanced inflation devices
Opportunity
• Expanding access to interventional care in emerging markets
Market Players
The key market players for Middle East and Africa inflation device market are listed below:
• Boston Scientific Corporation
• BD
• Olympus Corporation
• Merit Medical Systems
• Medtronic
• Teleflex Incorporated
• CONMED Corporation
• Integra LifeSciences Corporation
• Vygon SAS
• Advin Health Care

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET 28
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 30
2 MARKET SEGMENTATION 32
2.1 MARKETS COVERED 32
2.2 GEOGRAPHICAL SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 34
2.4 CURRENCY AND PRICING 34
2.5 DBMR TRIPOD DATA VALIDATION MODEL 35
2.6 MULTIVARIATE MODELLING 38
2.7 TYPE LIFELINE CURVE 38
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.9 DBMR MARKET POSITION GRID 40
2.10 VENDOR SHARE ANALYSIS 41
2.11 MARKET END USER COVERAGE GRID 42
2.12 SECONDARY SOURCES 43
2.13 ASSUMPTIONS 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 51
4.1 PESTAL ANALYSIS 52
4.2 COST ANALYSIS BREAKDOWN: MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET 53
4.3 HEALTHCARE ECONOMY 54
4.3.1 HEALTHCARE EXPENDITURE 54
4.3.2 CAPITAL EXPENDITURE (CAPEX) 54
4.3.3 CAPEX TRENDS 54
4.3.4 CAPEX ALLOCATION 54
4.3.5 FUNDING SOURCES 54
4.3.6 INDUSTRY BENCHMARKS 54
4.3.7 HEALTHCARE EXPENDITURE RATIO IN OVERALL GDP 54
4.3.8 HEALTHCARE SYSTEM STRUCTURE 55
4.3.9 GOVERNMENT POLICIES 55
4.3.10 ECONOMIC DEVELOPMENT 55
4.4 INDUSTRY INSIGHTS 56
4.5 PENETRATION AND GROWTH PROSPECT MAPPING: MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET 59
4.6 KEY PRICING STRATEGIES: MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET 61
4.7 INNOVATION TRACKER AND STRATEGIC ANALYSIS: MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET 63
4.8 OPPORTUNITY MAP ANALYSIS. 66
4.9 REIMBURSEMENT FRAMEWORK – MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET 68
4.10 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR. 70
4.10.1 MIDDLE EAST AND AFRICA VS. REGIONAL TARIFF STRUCTURES 70
4.10.2 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY 70
4.10.3 TARIFF REGULATIONS IN KEY MARKETS 70
4.11 TARIFFS ON MEDICAL DEVICES & EQUIPMENT 71
4.11.1 IMPORT/EXPORT DUTIES ON MEDICAL EQUIPMENT 71
4.11.2 IMPACT ON PRICING AND AVAILABILITY OF HIGH-END MEDICAL TECHNOLOGY 71
4.11.3 CASE STUDIES OF TARIFF CHANGES AFFECTING THE INDUSTRY 71
4.11.4 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES 71
4.11.5 TARIFF EXEMPTIONS AND INCENTIVES 71
4.11.6 DUTY-FREE IMPORTS FOR ESSENTIAL MEDICINES AND VACCINES 71
4.11.7 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN 71
4.11.8 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN REDUCING TARIFFS 72
4.12 TECHNOLOGY ROADMAP: MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET 73
4.13 VALUE CHAIN ANALYSIS: MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET 74
5 REGULATORY COMPLIANCE: MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET 76
5.1 REGULATORY AUTHORITIES 76
5.2 REGULATORY SUBMISSIONS 77
5.3 INTERNATIONAL HARMONIZATION 77
5.4 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS 78
5.5 REGULATORY CHALLENGES AND STRATEGIES 78
6 MARKET OVERVIEW 79
6.1 DRIVERS 81
6.1.1 RISING CASE OF CARDIOVASCULAR DISEASES 81
6.1.2 WIDE RANGE OF APPLICATIONS OF INFLATION DEVICES 81
6.1.3 INCREASING NUMBER OF MINIMALLY INVASIVE SURGERIES 82
6.1.4 AGING POPULATION AND CHRONIC DISEASE BURDEN 82
6.2 RESTRAINTS 84
6.2.1 HIGH COST OF ADVANCED INFLATION DEVICES 84
6.2.2 MAINTENANCE AND TRAINING REQUIREMENTS 84
6.3 OPPORTUNITIES 85
6.3.1 EXPANDING ACCESS TO INTERVENTIONAL CARE IN EMERGING MARKETS 85
6.3.2 TECHNOLOGICAL ADVANCEMENTS IN INFLATION DEVICES 85
6.3.3 STRATEGIC PARTNERSHIPS AND ACQUISITIONS 86
6.4 CHALLENGES 87
6.4.1 LOW-COST ALTERNATIVES OF INFLATION DEVICES 87
6.4.2 SHORTAGE OF HEALTHCARE PROFESSIONALS LIMITING DEVICE UTILIZATION 87
7 MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET, BY TYPE 89
7.1 OVERVIEW 90
7.2 ANALOG INFLATION DEVICE 93
7.2.1 20ML INFLATION DEVICE 93
7.2.2 25ML INFLATION DEVICE 93
7.2.3 30ML INFLATION DEVICE 94
7.2.4 60ML INFLATION DEVICE 94
7.3 DIGITAL INFLATION DEVICE 94
7.3.1 30ML INFLATION DEVICE 95
7.3.2 25ML INFLATION DEVICE 95
7.3.3 20ML INFLATION DEVICE 95
7.3.4 60ML INFLATION DEVICE 95
8 MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET, BY CAPACITY 96
8.1 OVERVIEW 97
8.2 20ML INFLATION DEVICE 100
8.3 25ML INFLATION DEVICE 100
8.4 30ML INFLATION DEVICE 101
8.5 60ML INFLATION DEVICE 101
9 MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET, BY PRESSURE 102
9.1 OVERVIEW 103
9.2 30 ATM 106
9.3 40 ATM 106
9.4 55 ATM 107
9.5 OTHERS 107
10 MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET, BY APPLICATION 108
10.1 OVERVIEW 109
10.2 INTERVENTIONAL CARDIOLOGY 112
10.3 PERIPHERAL VASCULAR PROCEDURES 112
10.4 INTERVENTIONAL RADIOLOGY 113
10.5 UROLOGICAL PROCEDURES 113
10.6 GASTROENTEROLOGICAL PROCEDURES 114
10.7 OTHERS 114
11 MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET, BY DISTRIBUTION CHANNEL 115
11.1 OVERVIEW 116
11.2 DIRECT TENDER 119
11.3 RETAIL SALES 119
11.4 THIRD PARTY DISTRIBUTORS 120
12 MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET, BY END USER 121
12.1 OVERVIEW 122
12.2 HOSPITALS 125
12.3 INTERVENTIONAL LABORATORIES 125
12.4 CLINICS 126
13 MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET, BY FUNCTION 127
13.1 OVERVIEW 128
13.2 STENT DEPLOYMENT 131
13.3 FLUID DELIVERY 131
14 MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET, BY REGION 132
14.1 MIDDLE EAST AND AFRICA 135
14.1.1 SAUDI ARABIA 139
14.1.2 SOUTH AFRICA 142
14.1.3 U.A.E. 145
14.1.4 EGYPT 148
14.1.5 ISRAEL 151
14.1.6 REST OF MIDDLE EAST AND AFRICA 154
15 MIDDLE EAST AND AFRICA INFLATION DEVICE MARKET, COMPANY LANDSCAPE 155
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 155
16 SWOT ANALYSIS 156
17 COMPANY PROFILE 157
17.1 BOSTON SCIENTIFIC CORPORATION 157
17.1.1 COMPANY SNAPSHOT 157
17.1.2 REVENUE ANALYSIS 158
17.1.3 COMPANY SHARE ANALYSIS 158
17.1.4 PRODUCT PORTFOLIO 159
17.1.5 RECENT DEVELOPMENT 159
17.2 BD 160
17.2.1 COMPANY SNAPSHOT 160
17.2.2 REVENUE ANALYSIS 160
17.2.3 COMPANY SHARE ANALYSIS 161
17.2.4 PRODUCT PORTFOLIO 161
17.2.5 RECENT DEVELOPMENT 161
17.3 B. BRAUN INTERVENTIONAL SYSTEMS INC. 162
17.3.1 COMPANY SNAPSHOT 162
17.3.2 COMPANY SHARE ANALYSIS 162
17.3.3 PRODUCT PORTFOLIO 163
17.3.4 RECENT DEVELOPMENT 164
17.4 OLYMPUS CORPORATION 165
17.4.1 COMPANY SNAPSHOT 165
17.4.2 REVENUE ANALYSIS 165
17.4.3 COMPANY SHARE ANALYSIS 166
17.4.4 PRODUCT PORTFOLIO 166
17.4.5 RECENT DEVELOPMENT 167
17.5 MERIT MEDICAL SYSTEMS 168
17.5.1 COMPANY SNAPSHOT 168
17.5.2 REVENUE ANALYSIS 168
17.5.3 COMPANY SHARE ANALYSIS 169
17.5.4 PRODUCT PORTFOLIO 169
17.5.5 RECENT DEVELOPMENTS 170
17.6 ADVANCED LIFESCIENCES PVT. LTD. 171
17.6.1 COMPANY SNAPSHOT 171
17.6.2 PRODUCT PORTFOLIO 171
17.6.3 RECENT DEVELOPMENT 173
17.7 ADVIN HEALTH CARE 174
17.7.1 COMPANY SNAPSHOT 174
17.7.2 PRODUCT PORTFOLIO 174
17.7.3 RECENT DEVELOPMENT 174
17.8 ATRION MEDICAL 175
17.8.1 COMPANY SNAPSHOT 175
17.8.2 REVENUE ANALYSIS 175
17.8.3 PRODUCT PORTFOLIO 176
17.8.4 RECENT DEVELOPMENT 176
17.9 CONMED CORPORATION 177
17.9.1 COMPANY SNAPSHOT 177
17.9.2 REVENUE ANALYSIS 177
17.9.3 PRODUCT PORTFOLIO 178
17.9.4 RECENT DEVELOPMENT 178
17.10 COOK 179
17.10.1 COMPANY SNAPSHOT 179
17.10.2 PRODUCT PORTFOLIO 179
17.10.3 RECENT NEWS 179
17.11 ELITE MEDTEK(JIANGSU) CO., LTD 180
17.11.1 COMPANY SNAPSHOT 180
17.11.2 PRODUCT PORTFOLIO 180
17.11.3 RECENT DEVELOPMENT 180
17.12 INTEGRA LIFESCIENCES CORPORATION 181
17.12.1 COMPANY SNAPSHOT 181
17.12.2 REVENUE ANALYSIS 181
17.12.3 PRODUCT PORTFOLIO 182
17.12.4 RECENT DEVELOPMENT 183
17.13 MEDORAH MEDITEK PVT. LTD. 184
17.13.1 COMPANY SNAPSHOT 184
17.13.2 PRODUCT PORTFOLIO 184
17.13.3 RECENT DEVELOPMENT 184
17.14 MEDTRONIC 185
17.14.1 COMPANY SNAPSHOT 185
17.14.2 REVENUE ANALYSIS 185
17.14.3 PRODUCT PORTFOLIO 186
17.14.4 RECENT DEVELOPMENT 186
17.15 SMT 187
17.15.1 COMPANY SNAPSHOT 187
17.15.2 PRODUCT PORTFOLIO 187
17.15.3 RECENT DEVELOPMENT 187
17.16 SPECTRUM MEDTECH PVT. LTD. 188
17.16.1 COMPANY SNAPSHOT 188
17.16.2 PRODUCT PORTFOLIO 188
17.16.3 RECENT DEVELOPMENT 188
17.17 SURETECH MEDICAL INC. 189
17.17.1 COMPANY SNAPSHOT 189
17.17.2 PRODUCT PORTFOLIO 189
17.17.3 RECENT DEVELOPMENT 189
17.18 TELEFLEX INCORPORATED 190
17.18.1 COMPANY SNAPSHOT 190
17.18.2 REVENUE ANALYSIS 190
17.18.3 PRODUCT PORTFOLIO 191
17.18.4 RECENT DEVELOPMENT 191
17.19 US ENDOVASCULAR, LLC. 192
17.19.1 COMPANY SNAPSHOT 192
17.19.2 PRODUCT PORTFOLIO 192
17.19.3 RECENT DEVELOPMENT 193
17.20 VYGON SAS 194
17.20.1 COMPANY SNAPSHOT 194
17.20.2 PRODUCT PORTFOLIO 194
17.20.3 RECENT DEVELOPMENT 194
18 QUESTIONNAIRE 195
19 RELATED REPORTS 199